Chennai Meenakshi Multispeciality Hospital Ltd vs Manipal Health Enterprises Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Nov 01, 2026

Key Highlights

The Latest Trading Price of Chennai Meenakshi Multispeciality Hospital Ltd is ₹ 33.15 as of 30 Oct 15:30 . The P/E Ratio of Chennai Meenakshi Multispeciality Hospital Ltd changed from 0 on March 2021 to 0 on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe P/E Ratio of Manipal Health Enterprises Ltd changed from 0 on March 2021 to 0 on March 2026 . This represents a CAGR of 0.0% over 6 years The Market Cap of Chennai Meenakshi Multispeciality Hospital Ltd changed from ₹ 0 crore on March 2021 to ₹ 0 crore on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe Market Cap of Manipal Health Enterprises Ltd changed from ₹ 0 crore on March 2021 to ₹ 0 crore on March 2026 . This represents a CAGR of 0.0% over 6 years The revenue of Chennai Meenakshi Multispeciality Hospital Ltd for the Jun '26 is ₹ 0 crore as compare to the Mar '26 revenue of ₹ 0 crore. This represent the decline of 0% The revenue of Manipal Health Enterprises Ltd for the Jun '26 is ₹ 3165 crore as compare to the Mar '26 revenue of ₹ 2917 crore. This represent the growth of 8.48% The ebitda of Chennai Meenakshi Multispeciality Hospital Ltd for the Jun '26 is ₹ 0 crore as compare to the Mar '26 ebitda of ₹ 0 crore. This represent the decline of 0% The ebitda of Manipal Health Enterprises Ltd for the Jun '26 is ₹ 795.7 crore as compare to the Mar '26 ebitda of ₹ 717.81 crore. This represent the growth of 10.85% The net profit of Chennai Meenakshi Multispeciality Hospital Ltd changed from ₹ 0 crore to ₹ 0 crore over 5 quarters. This represents a CAGR of 0.0% The net profit of Manipal Health Enterprises Ltd changed from ₹ 254.04 crore to ₹ 243.43 crore over 5 quarters. This represents a CAGR of -3.36% The Dividend Payout of Chennai Meenakshi Multispeciality Hospital Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe Dividend Payout of Manipal Health Enterprises Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 years .

About Chennai Meenakshi Multispeciality Hospital Ltd

Chennai Meenakshi Multispeciality Hospital Limited, formerly known as Devaki Hospital Limited, was incorporated in 1990.
The Company name was changed from Devaki Hospital Limited to Chennai Meenakshi Multispeciality Hospital Limited in October, 2007.
It is a 100-bedded hospital located in the heart of Chennai at Mylapore.
The hospital has an infrastructure comprising of around 105 Beds including ICU Beds, Operating Theatre, a modern dialysis Unit besides a host of other facilities.
The Company has a pool of talented and experienced doctors who are further supported by a team of highly qualified and experienced and dedicated support staff and cutting edge technology. The Company operate into various departments like Cardiology Department; Casualty Department; Diagnostic Services; Intensive Care Unit; Nephrology Department and Physiotherapy Department.

About Manipal Health Enterprises Ltd

Manipal Health Enterprises Limited was originally incorporated in Bengaluru, Karnataka as Manipal Health Enterprises Private Limited' as a private limited company dated February 15, 2010, issued by the RoC. Subsequently, Company was converted to a public limited company and the name was changed to Manipal Health Enterprises Limited and a fresh certificate of incorporation dated December 24, 2025 was issued by the Central Processing Centre.
The Company is engaged in the business of running/managing hospitals, and providing healthcare services.
It operates through various Hospitals/clinics providing Healthcare services and diagnostic centres, in India. The Company commenced its operations at Bengaluru, Karnataka, Near Manipal Hospital Old Airport Road in year 1991.
In 1993, it expanded presence in hospitals in Bengaluru and further to Goa in 1994, commenced operations in Mangalore at KMC Hospital in 1997.

FAQs for the comparison of Chennai Meenakshi Multispeciality Hospital Ltd and Manipal Health Enterprises Ltd

Which company has a larger market capitalization, Chennai Meenakshi Multispeciality Hospital Ltd or Manipal Health Enterprises Ltd?

Market cap of Chennai Meenakshi Multispeciality Hospital Ltd is 24 Cr while Market cap of Manipal Health Enterprises Ltd is 87,926 Cr

What are the key factors driving the stock performance of Chennai Meenakshi Multispeciality Hospital Ltd and Manipal Health Enterprises Ltd?

The stock performance of Chennai Meenakshi Multispeciality Hospital Ltd and Manipal Health Enterprises Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Chennai Meenakshi Multispeciality Hospital Ltd and Manipal Health Enterprises Ltd?

As of November 1, 2026, the Chennai Meenakshi Multispeciality Hospital Ltd stock price is INR ₹33.15. On the other hand, Manipal Health Enterprises Ltd stock price is INR ₹668.45.

How do dividend payouts of Chennai Meenakshi Multispeciality Hospital Ltd and Manipal Health Enterprises Ltd compare?

To compare the dividend payouts of Chennai Meenakshi Multispeciality Hospital Ltd and Manipal Health Enterprises Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.